Decreased circulating C3 levels and mesangial C3 deposition predict renal outcome in patients with iga nephropathy

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Kim, Seung Jun ^a   Koo, Hyang Mo ^a   Lim, Beom Jin ^a   Oh, Hyung Jung ^a   Yoo, Dong Eun ^a   Shin, Dong Ho ^a   Lee, Mi Jung ^a   Doh, Fa Mee ^a   Park, Jung Tak ^a   Yoo, Tae Hyun ^a   Kang, Shin Wook ^a   Choi, Kyu Hun ^a   Jeong, Hyeon Joo ^a   Han, Seung Hyeok ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; CREATININE;

ADULT; ARTICLE; COHORT ANALYSIS; COMPLEMENT ACTIVATION; COMPLEMENT BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; OBSERVATIONAL STUDY; PROTEIN LOCALIZATION; RISK FACTOR;

ADULT; BIOPSY; COHORT STUDIES; COMPLEMENT C3; CREATININE; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS, IGA; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; ROC CURVE; YOUNG ADULT;

EID: 84863691899     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040495     Document Type: Article

References (43)

1. D'Amico G, (1987) The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 64: 709-727.
2. D'Amico G, Colasanti G, Barbiano di Belgioioso G, Fellin G, Ragni A, et al. (1987) Long-term follow-up of IgA mesangial nephropathy: clinico-histological study in 374 patients. Semin Nephrol 7: 355-358.
3. Li PK, Ho KK, Szeto CC, Yu L, Lai FM, (2002) Prognostic indicators of IgA nephropathy in the Chinese-clinical and pathological perspectives. Nephrol Dial Transplant 17: 64-69.
4. D'Amico G, (2004) Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 24: 179-196.
5. Walsh M, Sar A, Lee D, Yilmaz S, Benediktsson H, et al. (2010) Histopathologic features aid in predicting risk for progression of IgA nephropathy. Clin J Am Soc Nephrol 5: 425-430.
6. Oortwijn BD, Eijgenraam JW, Rastaldi MP, Roos A, Daha MR, et al. (2008) The role of secretory IgA and complement in IgA nephropathy. Semin Nephrol 28: 58-65.
7. Hiemstra PS, Gorter A, Stuurman ME, Van Es LA, Daha MR, (1987) Activation of the alternative pathway of complement by human serum IgA. Eur J Immunol 17: 321-326.
8. Stad RK, Bruijn JA, van Gijlswijk-Janssen DJ, van Es LA, Daha MR, (1993) An acute model for IgA-mediated glomerular inflammation in rats induced by monoclonal polymeric rat IgA antibodies. Clin Exp Immunol 92: 514-521.
9. Nakagawa H, Suzuki S, Haneda M, Gejyo F, Kikkawa R, (2000) Significance of glomerular deposition of C3c and C3d in IgA nephropathy. Am J Nephrol 20: 122-128.
10. Endo M, Ohi H, Ohsawa I, Fujita T, Matsushita M, (1998) Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy. Nephrol Dial Transplant 13: 1984-1990.
11. Roos A, Rastaldi MP, Calvaresi N, Oortwijn BD, Schlagwein N, et al. (2006) Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J Am Soc Nephrol 17: 1724-1734.
12. Espinosa M, Ortega R, Gomez-Carrasco JM, Lopez-Rubio F, Lopez-Andreu M, et al. (2009) Mesangial C4d deposition: a new prognostic factor in IgA nephropathy. Nephrol Dial Transplant 24: 886-891.
13. Wyatt RJ, Kanayama Y, Julian BA, Negoro N, Sugimoto S, et al. (1987) Complement activation in IgA nephropathy. Kidney Int 31: 1019-1023.
14. Zwirner J, Burg M, Schulze M, Brunkhorst R, Gotze O, et al. (1997) Activated complement C3: a potentially novel predictor of progressive IgA nephropathy. Kidney Int 51: 1257-1264.
15. Nasr SH, D'Agati VD, (2011) IgA-dominant postinfectious glomerulonephritis: a new twist on an old disease. Nephron Clin Pract 119: c18-25; discussion c26.
16. Giannakakis K, Faraggiana T, (2011) Histopathology of lupus nephritis. Clin Rev Allergy Immunol 40: 170-180.
17. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, et al. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470.
18. Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, et al. (2009) The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 76: 534-545.
19. Kim JK, Kim JH, Lee SC, Kang EW, Chang TI, et al. (2012) Clinical features and outcomes of IgA nephropathy with nephrotic syndrome. Clin J Am Soc Nephrol 7: 427-436.
20. Floege J, Feehally J, (2000) IgA nephropathy: recent developments. J Am Soc Nephrol 11: 2395-2403.
21. Komatsu H, Fujimoto S, Hara S, Sato Y, Yamada K, et al. (2004) Relationship between serum IgA/C3 ratio and progression of IgA nephropathy. Intern Med 43: 1023-1028.
22. Radford MG Jr, Donadio JV Jr, Bergstralh EJ, Grande JP, (1997) Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 8: 199-207.
23. Myllymaki JM, Honkanen TT, Syrjanen JT, Helin HJ, Rantala IS, et al. (2007) Severity of tubulointerstitial inflammation and prognosis in immunoglobulin A nephropathy. Kidney Int 71: 343-348.
24. Janssen U, Bahlmann F, Kohl J, Zwirner J, Haubitz M, et al. (2000) Activation of the acute phase response and complement C3 in patients with IgA nephropathy. Am J Kidney Dis 35: 21-28.
25. Tsokos GC, (2004) Exploring complement activation to develop biomarkers for systemic lupus erythematosus. Arthritis Rheum 50: 3404-3407.
26. Tomino Y, Suzuki S, Imai H, Saito T, Kawamura T, et al. (2000) Measurement of serum IgA and C3 may predict the diagnosis of patients with IgA nephropathy prior to renal biopsy. J Clin Lab Anal 14: 220-223.
27. van der Boog PJ, van Kooten C, van Seggelen A, Mallat M, Klar-Mohamad N, et al. (2004) An increased polymeric IgA level is not a prognostic marker for progressive IgA nephropathy. Nephrol Dial Transplant 19: 2487-2493.
28. Feehally J, Beattie TJ, Brenchley PE, Coupes BM, Mallick NP, et al. (1986) Sequential study of the IgA system in relapsing IgA nephropathy. Kidney Int 30: 924-931.
29. Gharavi AG, Moldoveanu Z, Wyatt RJ, Barker CV, Woodford SY, et al. (2008) Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J Am Soc Nephrol 19: 1008-1014.
30. Suzuki H, Kiryluk K, Novak J, Moldoveanu Z, Herr AB, et al. (2011) The pathophysiology of IgA nephropathy. J Am Soc Nephrol 22: 1795-1803.
31. Cook HT, Botto M, (2006) Mechanisms of Disease: the complement system and the pathogenesis of systemic lupus erythematosus. Nat Clin Pract Rheumatol 2: 330-337.
32. Ammitzboll CG, Thiel S, Ellingsen T, Deleuran B, Jorgensen A, et al. (2011) Levels of lectin pathway proteins in plasma and synovial fluid of rheumatoid arthritis and osteoarthritis. Rheumatol Int.
33. Ohsawa I, Inoshita H, Ishii M, Kusaba G, Sato N, et al. (2010) Metabolic impact on serum levels of complement component 3 in Japanese patients. J Clin Lab Anal 24: 113-118.
34. Hernandez-Mijares A, Jarabo-Bueno MM, Lopez-Ruiz A, Sola-Izquierdo E, Morillas-Arino C, et al. (2007) Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors. Int J Obes (Lond) 31: 927-932.
35. Palmblad J, Fohlin L, Norberg R, (1979) Plasma levels of complement factors 3 and 4, orosomucoid and opsonic functions in anorexia nervosa. Acta Paediatr Scand 68: 617-618.
36. Sigal LH, Snyder BK, (1989) Low serum complement levels in anorexia nervosa. Am J Dis Child 143: 1391-1392.
37. Flierl MA, Gaudiani JL, Sabel AL, Long CS, Stahel PF, et al. (2011) Complement C3 serum levels in anorexia nervosa: a potential biomarker for the severity of disease? Ann Gen Psychiatry 10: 16.
38. Roufosse CA, Cook HT, (2009) Pathological predictors of prognosis in immunoglobulin A nephropathy: a review. Curr Opin Nephrol Hypertens 18: 212-219.
39. Chan LY, Leung JC, Lai KN, (2004) Novel mechanisms of tubulointerstitial injury in IgA nephropathy: a new therapeutic paradigm in the prevention of progressive renal failure. Clin Exp Nephrol 8: 297-303.
40. Kusaba G, Ohsawa I, Ishii M, Inoshita H, Takagi M, et al. (2012) Significance of broad distribution of electron-dense deposits in patients with IgA nephropathy. Med Mol Morphol 45: 29-34.
41. El Karoui K, Hill GS, Karras A, Jacquot C, Moulonguet L, et al. (2012) A clinicopathologic study of thrombotic microangiopathy in IgA nephropathy. J Am Soc Nephrol 23: 137-148.
42. Birmingham DJ, Irshaid F, Nagaraja HN, Zou X, Tsao BP, et al. (2010) The complex nature of serum C3 and C4 as biomarkers of lupus renal flare. Lupus 19: 1272-1280.
43. Geddes CC, Rauta V, Gronhagen-Riska C, Bartosik LP, Jardine AG, et al. (2003) A tricontinental view of IgA nephropathy. Nephrol Dial Transplant 18: 1541-1548.